Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Anjali T Owens Added: 9 months ago
Navigate the rapidly evolving treatment landscape for hypertrophic cardiomyopathy with Dr Anjali Tiku Owens, a renowned expert in inherited cardiovascular diseases and advanced heart failure.This comprehensive presentation, part of the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program, explores both established and emerging therapeutic approaches for obstructive and non… View more
Job title: Professor of Cardiovascular Medicine
Dr Michael Fowler is a Professor of Cardiovascular Medicine at Stanford Hospital and Clinics. Dr Fowler attended the Charing Cross Hospital Medical School, London, England and is a fellow of the Royal College of Physicians. He came to Stanford University on a British Heart Foundation/American Heart Association reciprocal fellowship award. Dr Fowler has specialised in the treatment and research… View more
Research Area(s) / Expertise: Job title: Co-Director, Center for Cardiometabolic Implementation Science
Dr. Muthiah Vaduganathan is a cardiologist and clinical trialist based in Boston, Massachusetts, United States. He practices at Brigham and Women’s Hospital and holds an academic appointment at Harvard Medical School. Dr. Vaduganathan is internationally recognised for his work at the intersection of cardiovascular, kidney, and metabolic disease, with a particular focus on translating evidence… View more
Research Area(s) / Expertise: Job title: Professor Emeritus; Founder and Chairman of CVCT Société Civile
Prof Faiez Zannad was born in Monastir, Tunisia in 1951 and later moved to pursue his medical education and research in Europe. He trained in cardiology and pharmacology across institutions in France and the United Kingdom, including Nancy, Lyon, and Oxford. Over the course of his career, he has lived and worked primarily in Nancy, France, where he has held clinical, academic, and research… View more
Job title: Assistant Professor of Medicine in the Division of Cardiology and Director of the Pulmonary Vascular Diseases Program
Myung H Park, MD, FACC, is an Assistant Professor of Medicine in the Division of Cardiology and Director of the Pulmonary Vascular Diseases Program at the University of Maryland School of Medicine. She is a member of the American College of Cardiology, the Heart Failure Society of America, the International Society of Heart and Lung Transplantation, and the Pulmonary Hypertension Association… View more
Research Area(s) / Expertise:

Cardio-oncology

Heart Failure

Echocardiography & Ultrasound

Job title: Cardiologist
Dr Massimiliano Camilli works as a cardiologist at Policlinico Universitario Agostino Gemelli in Rome. His main research and clinical focus are cardio-oncology, advanced cardiovascular imaging and heart failure. He also teaches and supports University Master's students in echocardiography.Dr Camilli graduated at University Campus Biomedico in Rome in 2016 and then attended his residency in… View more
Research Area(s) / Expertise:

Heart Failure

MI/ACS

Intervention

Job title: Cardiology Fellow and Clinical Investigator
Dr Josip A Borovac, MD, PhD, FHFA, FESC, is a faculty member at the Department of Pathophysiology, University of Split School of Medicine, and an interventional cardiology fellow at the Department of Cardiovascular Diseases, University Hospital of Split in Split, Croatia. He currently serves as a Scientific Committee Member for the Heart Failure Association (HFA) Committee on Coronary Artery… View more
Research Area(s) / Expertise: Job title: Chief of Cardiology
Dr Clyde W Yancy, is Vice-Dean of Diversity & Inclusion, Northwestern University, Feinberg School of Medicine in Chicago, US.He concomitantly serves as Chief of Cardiology at Northwestern University, Feinberg School of Medicine, and Associate Director of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital. He holds the Magerstadt Endowed Professor of Medicine Chair and also holds… View more
Author(s): Added: 1 year ago
AHA Conference 2024 - Primary safety and efficacy results from ENDEAVOR investigating the effect of myeloperoxidase inhibition with mitiperstat (AstraZeneca) on symptoms and exercise capacity in patients with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF).Dr Sanjiv Shah (Bluhm Cardiovascular Institute, Chicago, US) joins us onsite at AHA Conference to discuss the… View more